Thermo Fisher Scientific has announced a new technology collaboration with the research centre SRI International.
The agreement will allow researchers carrying out high-resolution Orbitrap LC/MS experiments to combine their results with highly curated and organism-specific metabolic pathway and genome data for quick and effective small molecule research and analysis.
“Thermo Fisher Scientific is allying with SRI International to offer enhanced small molecule research capabilities to customers.“
Users of the Thermo Scientific Compound Discoverer 2.1 software platform will have direct access to SRI International's BioCyc, a collection of 9,300 databases that provide electronic reference sources on metabolic pathways and genomes.
It means they will be able to automatically overlay statistical data on to these pathways to facilitate the biological interpretation of results obtained from a metabolomics experiment, providing a clearer understanding of biological processes.
Andreas Huhmer, director of proteomics and metabolomics marketing, chromatography and mass spectrometry at Thermo Fisher, said: "Today, metabolomics researchers can measure thousands of small molecules, but it can be challenging to know which cellular systems are behaving differently in the studied condition compared to a control."
With over 20 years of experience within the science market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current science roles we have available, you can search for the latest job roles, register your details, or contact the team today.See all the latest jobs in Science